US heatwaves threaten European plasma stability

The Red Cross reported that national blood stocks plummeted by 25 percent throughout June, marking the second such emergency declaration since the onset of the COVID-19 pandemic in January 2022. Compounding the strain, hospitals experienced a surge in trauma care requirements, with weekly distributions exceeding expectations by 3,500 units during early July. Nonprofit officials cite a convergence of extreme heat, food-borne illnesses, and hazardous air quality as the primary drivers behind the historic slump in donor turnout.

While European nations maintain self-sufficiency for whole blood, the continent remains tethered to the American market for essential plasma derivatives. This structural dependency leaves European healthcare systems vulnerable to fluctuations in US public health conditions. As climate-driven disruptions become more frequent, the current model of sourcing 25 percent of EU plasma from across the Atlantic faces increasing scrutiny regarding its long-term reliability.